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‘‘So be sure when you step, Step with
care and great tact. And remember
that life’s A Great Balancing Act.
Just never forget to be dexterous
and deft, and never mix up your right
foot with your left.’’
—Dr. Seuss, Oh, The Places You’ll
Go! Random House, 1990.
The benefits and risks of a cell’s use
of O2 can be a tricky balance. Con-
sumption of O2 by mitochondria
greatly enhances the efficiency of aer-
obic metabolism, allowing generation
of 15-fold more ATP than is possible
by anaerobic glycolysis alone. Most
O2 consumption occurs in the electron
transport chain. Under normal condi-
tions, the electron transport chain takes
high-energy electrons from NADH or
FADH2 to generate a proton concentra-
tion gradient and membrane potential
gradient between the inner mitochon-
drial space and the mitochondrial ma-
trix. O2 plays a key role by capturing
four low energy electrons coming out
of the electron transport chain, forming
H2O in the process. The proton
gradient is used to power ATP syn-
thase, which harnesses the energy
from protons flowing back into the
mitochondrial matrix to phosphorylate
ADP, yielding ATP. Yet if a high-
energy electron leaks from the electron
transport chain too early, it may be
captured by O2 to form the reactive
oxygen species (ROS) known as
superoxide (O2). Superoxide can behttp://dx.doi.org/10.1016/j.bpj.2013.08.013
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extremely high affinity for electrons,
ripping them away from nearby pro-
teins, lipids, and nucleic acids via
oxidation. Indeed, ROS species play a
key role in a wide range of pathologies
such as atherosclerosis (1), Alzheimer’s
disease (2), and cancer (3). Therefore
the cell needs to balance the benefits
of an efficient aerobic metabolism
with the risks of generating toxic ROS.
Although the interplay between ATP
synthesis and ROS generation has
been studied intensively, there have
emerged apparent inconsistencies be-
tween explanations of the conditions
and mechanisms responsible for mito-
chondrial ROS production from iso-
lated mitochondria and intact cells.
As an attempt to resolve these discrep-
ancies, Aon et al. (4) showed that ROS
overflow is minimal at intermediate
redox states, increasing in either highly
reduced/high mitochondrial membrane
potential environments (e.g., high
workload) or highly oxidized environ-
ments (e.g., hypoxia). ROS increased
in highly reduced environments due
to enhanced ROS production, whereas
ROS increased in highly oxidative
environments due to lower ROS scav-
enging. Thus increased mitochondrial
ROS arises from imbalance of ROS
production and ROS scavenging.
Based on this data, Aon et al. (4) pro-
posed the Redox-Optimized ROS
Balance hypothesis, that mitochondria
have evolved an optimal, intermediate
redox state to maximize energy output
while minimizing ROS overflow.
In this issue of the Biophysical
Journal, Gauthier et al. (5) develop a
mechanistic computational model to
better understand the mechanisms
underlying this complex balance be-
tween mitochondrial ROS production
and ROS scavenging. The model was
carefully validated against a range of
independent experimental data includ-
ing how ROS production changes as
a function of NADþ/NADH redox
potential, mitochondrial matrix pH,
substrate, respiratory state, and inhibi-
tion of complex I or III. Gauthier et al.(5) do a commendable job of describ-
ing conditions where model predic-
tions deviate from experimental data,
pointing toward contemporary gaps
where mechanisms remain to be iden-
tified. During conditions of reverse
electron transport, ROS production
from complex I has been proposed to
occur either at the flavin mononucleo-
tide site (6) or the quinone binding
site (7). Model variants based on either
of these two potential mechanisms
were able to accurately predict ROS
production with varying NADþ/
NADH redox potential (5), indicating
that further conditions for discrimi-
nating these mechanisms are still
required. By integrating the electron
transport chain model with a minimal
model of ROS scavenging, the authors
showed how large shifts in redox envi-
ronment in either direction (toward
oxidation or reduction) increase ROS
levels (see Fig. 1). Thus this model
provides a set of biophysical mecha-
nisms that are sufficient to predict the
main features of the Redox-Optimized
ROS Balance hypothesis and related
experimental data.
So what are the next steps? Gauthier
et al. (5) make a number of interesting
testable predictions that warrant new
experiments, including the relative
role of mitochondrial membrane
potential and NADH redox state on
ROS production and scavenging,
respectively. After further validation,
this model would be a highly useful
new, to our knowledge, module in
more comprehensive models of mito-
chondrial metabolism or multiscale
models connecting mitochondrial
ROS to cardiac electrophysiology.
Such a model would allow prediction
of multiscale feedbacks between mo-
lecular mechanisms of ROS produc-
tion/scavenging, calcium dynamics,
and ventricular arrhythmia. For ex-
ample, Christensen et al. (8) have
already modeled how oxidation of
calcium-calmodulin dependent protein
FIGURE 1 Balance of ROS production and
ROS scavenging depends on the mitochondrial
redox environment.
1288 Saucermankinase II prolonged the refractory
period of the action potential,
increasing susceptibility to conduction
block. Zhou et al. (9) showed how
ROS-induced ROS release can syn-
chronize mitochondrial depolarization
across the entire cell or even propagate
to ventricular fibrillation (10). Models
of bidirectional links between mito-Biophysical Journal 105(6) 1287–1288chondrial ROS and signaling networks
involved in apoptosis and cardiac hy-
pertrophy are needed as well (11–13).
Ultimately, iterative steps of care
(solid experimental validation) and
steps of deft (multiscale integration)
will allow progressive understanding
of the mechanisms and functional con-
sequences of mitochondrial ROS, a
challenging but critical balancing act.
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